152 related articles for article (PubMed ID: 14684381)
1. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice.
Tashiro M; Samuelson LC; Liddle RA; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G784-90. PubMed ID: 14684381
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin-dependent and calcineurin-independent signal transduction pathways activated as part of pancreatic growth.
Tashiro M; Dabrowski A; Guo L; Sans MD; Williams JA
Pancreas; 2006 Apr; 32(3):314-20. PubMed ID: 16628088
[TBL] [Abstract][Full Text] [Related]
3. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
4. Induction of early response genes in trypsin inhibitor-induced pancreatic growth.
Guo L; Sans MD; Gurda GT; Lee SH; Ernst SA; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G667-77. PubMed ID: 17095753
[TBL] [Abstract][Full Text] [Related]
5. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
[TBL] [Abstract][Full Text] [Related]
6. Regulator of calcineurin 1 controls growth plasticity of adult pancreas.
Gurda GT; Crozier SJ; Ji B; Ernst SA; Logsdon CD; Rothermel BA; Williams JA
Gastroenterology; 2010 Aug; 139(2):609-19, 619.e1-6. PubMed ID: 20438729
[TBL] [Abstract][Full Text] [Related]
7. Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice.
Crozier SJ; Sans MD; Guo L; D'Alecy LG; Williams JA
J Physiol; 2006 Jun; 573(Pt 3):775-86. PubMed ID: 16613881
[TBL] [Abstract][Full Text] [Related]
8. CCK-induced pancreatic growth is not limited by mitogenic capacity in mice.
Crozier SJ; Sans MD; Lang CH; D'Alecy LG; Ernst SA; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1148-57. PubMed ID: 18356533
[TBL] [Abstract][Full Text] [Related]
9. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
[TBL] [Abstract][Full Text] [Related]
10. Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain.
Luo J; Ma J; Yu DY; Bu F; Zhang W; Tu LH; Wei Q
Brain Res Bull; 2008 Jul; 76(5):464-8. PubMed ID: 18534252
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
[TBL] [Abstract][Full Text] [Related]
12. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
Merten KE; Jiang Y; Feng W; Kang YJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypergastrinemia and blockade of gastrin-receptors on pancreatic growth in the mouse.
Niederau C; Niederau M; Klonowski H; Lüthen R; Ferrell LD
Hepatogastroenterology; 1995; 42(4):423-31. PubMed ID: 8586382
[TBL] [Abstract][Full Text] [Related]
15. Precocious alteration of digestive enzyme activities in small intestine and pancreas by chronic oral administration of protease inhibitor in suckling rats.
Harada E; Syuto B
Comp Biochem Physiol A Comp Physiol; 1991; 100(2):467-72. PubMed ID: 1685962
[TBL] [Abstract][Full Text] [Related]
16. Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice.
Sato N; Suzuki S; Kanai S; Ohta M; Jimi A; Noda T; Takiguchi S; Funakoshi A; Miyasaka K
Jpn J Pharmacol; 2002 Jul; 89(3):290-5. PubMed ID: 12184735
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo.
Gurda GT; Guo L; Lee SH; Molkentin JD; Williams JA
Mol Biol Cell; 2008 Jan; 19(1):198-206. PubMed ID: 17978097
[TBL] [Abstract][Full Text] [Related]
18. The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval.
Lateef DM; Washington MC; Sayegh AI
Peptides; 2011 Jun; 32(6):1289-95. PubMed ID: 21453733
[TBL] [Abstract][Full Text] [Related]
19. Hormonal control of pancreatic growth.
Mainz DL; Black O; Webster PD
J Clin Invest; 1973 Sep; 52(9):2300-4. PubMed ID: 4727460
[TBL] [Abstract][Full Text] [Related]
20. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8.
Yamamoto M; Reeve JR; Keire DA; Green GM
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G866-79. PubMed ID: 15550556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
